Nouveau Life Pharmaceuticals, Inc.
Nouveau Life Pharmaceuticals, Inc.
Your view on NOUV
Overview
What the company does, where it operates, and who runs it.
About Nouveau Life Pharmaceuticals, Inc.
- Industry
- Agricultural - Commodities/Milling
- Sector
- Industrials
- CEO
- Brian Shibley
- Headquarters
- 401 East Las Olas Boulevard, Ft. Lauderdale, FL, US
- Industry
- Agricultural - Commodities/Milling
- Sector
- Industrials
- CEO
- Brian Shibley
- Headquarters
- 401 East Las Olas Boulevard, Ft. Lauderdale, FL, US
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012.
Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Nouveau Life Pharmaceuticals, Inc., and the rating behind it. NOUV last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Nouveau Life Pharmaceuticals, Inc.. Starting points for Nouveau Life Pharmaceuticals, Inc.: beta -0.49 — an Agricultural - Commodities/Milling name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Nouveau Life Pharmaceuticals, Inc.. Nouveau Life Pharmaceuticals, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Nouveau Life Pharmaceuticals, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Nouveau Life Pharmaceuticals, Inc.. Nouveau Life Pharmaceuticals, Inc. has reported as a listed company since 2003. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Nouveau Life Pharmaceuticals, Inc. valued side by side against its closest peers. Nouveau Life Pharmaceuticals, Inc. is measured against Agricultural - Commodities/Milling peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Nouveau Life Pharmaceuticals, Inc., and how their positions are changing. At a $90,000 market value, institutional positions materially move Nouveau Life Pharmaceuticals, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Nouveau Life Pharmaceuticals, Inc. executives and directors. Shares of Nouveau Life Pharmaceuticals, Inc. have traded between $0.0000 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Nouveau Life Pharmaceuticals, Inc.. Nouveau Life Pharmaceuticals, Inc. is a $90,000 Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Nouveau Life Pharmaceuticals, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Nouveau Life Pharmaceuticals, Inc.. Coverage tracks Nouveau Life Pharmaceuticals, Inc. within Agricultural - Commodities/Milling (Industrials). Press releases and market coverage, newest first.